Skip to content
MGTX·Nasdaq·US

MeiraGTx

MeiraGTx is a clinical-stage genetic medicines company focused on developing and commercializing gene therapies. It generates revenue from collaboration agreements, licensing, and related service arrangements tied to its therapeutic platforms and product candidates.

Thematic Position

Relationship Groups

Competitors1

Relationship details are part of the Pro plan.